Navigation Links
Solos Endoscopy, Inc.'s MammoView(TM) Product Line Receives New Purchase Orders Primarily from Prestigious Teaching Hospitals Across the Country
Date:9/21/2009

BOSTON, Sept. 21 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company is receiving multiple new purchase orders for its MammoView(TM) line of surgical endoscopy instruments from approximately 30 hospitals, which Solos has added to their client base over the last 12 months. More than half of the purchase orders are coming from teaching hospitals affiliated with prestigious public and private Universities across the Country.

In addition to providing the world's most advanced medical care, teaching hospitals educate and train the next generation of physicians. Every year, approximately 16,000 graduates of the nation's 130 medical schools begin their residency training at U.S. teaching hospitals. Physicians at these institutions have pioneered new, advanced medical procedures that are now staples of clinical care.

"The MammoView(TM) product line is revolutionary in that it employs advanced micro endoscopes and optical technology, which can detect precancerous and cancerous cells approximately five years before a mammogram would. For this reason, we expect to continue to receive an increase in new purchase orders, as well as re-orders, from highly-regarded University teaching hospitals," stated Bob Segersten, President of Solos Endoscopy, Inc.

Solos Endoscopy, Inc. recently announced that the Company has received multiple purchase orders for its MammoView(TM) line of surgical endoscopy instruments from the National Cancer Institute (NCI). NCI is 1 of 27 Institutes and Centers that comprise the U.S. National Institutes of Health, which is part of the U.S. Department of Health and Human Services.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Solos Endoscopy, Inc. Receives Purchase Order from the National Cancer Institute
2. Solos Endoscopy, Inc. Receives Purchase Order from One of the Major Healthcare Systems in Missouri
3. Apidra(R) SoloSTAR(R), the Easy-to-Use Insulin Delivery Device from sanofi-aventis, Now Available in the United States
4. Solos Endoscopy, Inc. Develops Specialized Endocoupler for the MammoView(TM)
5. Solos Endoscopy, Inc. Receives Purchase Order from Leading San Diego Healthcare Provider
6. Solos Endoscopy, Inc. Successfully Completes FDA Inspection
7. Solos Endoscopy, Inc. Receives Purchase Order from Major Connecticut Hospital for the MammoView(TM)
8. Solos Endoscopy, Inc.s Breast Endoscopy System Featured in January Issue of Outpatient Surgery Magazine
9. Solos Endoscopy, Inc.s MammoView(TM) Featured in December Issue of Surgical Products Magazine
10. Solos Endoscopy, Inc. Posts First Nine Months Financials for 2008 on Pinksheets.com
11. Solos Endoscopy, Inc. Receives Purchase Order from Cleveland Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Research and ... Market for Companion Diagnostic Tests" report to their offering. ... for Companion Diagnostics The World Market for ... personalized medicine diagnostics. Market analysis in the report includes the ... Market (In Vitro Diagnostic Kits) by Region (N. America, EU, ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology: